Ready A Randomized Trial Evaluating the Addition of Dasatinib To Docetaxel Therapy Trademark Details

This mark is dead with a status of Abandoned - No Statement of Use Filed. The last case file activity for this mark occured 11 years ago on Monday, December 24, 2012, according to the United State Patent & Trademark Office
Word Mark Ready a Randomized Trial Evaluating the Addition of Dasatinib to Docetaxel Therapy
Status Dead 606 — Abandoned - No Statement of Use Filed

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company
Serial Number 77724001
Status Date Monday, December 24, 2012
Filing Date Monday, December 24, 2012
Attorney Marilyn F. Kelly

Correspondent

Marilyn F. Kelly
Bristol-Myers Squibb Company
Trademark Department
345 Park Avenue
New York NY 10154

Case File Statements

Disclaimer with Predetermined Text "a Randomized Trial Evaluating the Addition of Dasatinib to Docetaxel Therapy"
Goods & Services Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use

Classifications

International Class Codes
042 — Class 42 includes mainly services provided by persons, individually or collectively, in relation to the theoretical and practical aspects of complex fields of activities; such services are provided by members of professions such as chemists, physicists, engineers, computer programmers, etc.
U.S. Class Codes 100, 101
Status 6 — Active
Status Date Friday, May 1, 2009
Primary Code 042

You must be signed in to print.

Once signed in, look for the PDF button.